NCT07209111
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07209111
Title A Clinical Study of MK-1084 in People With Advanced Solid Tumors (MK-1084-014) (KANDLELIT-014)
Acronym KANDLELIT-014
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NOR | ESP

Facility Status City State Zip Country Details
START Midwest ( Site 1103) RECRUITING Grand Rapids Michigan 49546 United States Details
START Mountain Region ( Site 1106) RECRUITING West Valley City Utah 84119 United States Details
Haukeland universitetssykehus ( Site 2102) RECRUITING Bergen Hordaland 5021 Norway Details
Oslo universitetssykehus, Radiumhospitalet ( Site 2101) RECRUITING Oslo 0379 Norway Details
Seoul National University Hospital ( Site 2301) RECRUITING Seoul 03080 South Korea Details
Asan Medical Center ( Site 2302) RECRUITING Seoul 05505 South Korea Details
Samsung Medical Center ( Site 2300) RECRUITING Seoul 06351 South Korea Details
Hospital Clinic de Barcelona ( Site 2402) RECRUITING Barcelona 08036 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field